ORASOME

compositions as prophylaxis, diagnostics or treatments for human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan disease; drug delivery agents and formulations consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals and other chemical, synthetic or biologic payloads that can be administered in a range of approaches; pharmaceutical and prophylactic preparations, namely, a drug delivery system for the targeting, delivery, and release of a wide range of therapeutic agents, pharmaceuticals and other chemical, synthetic or biologic molecules and reagents, namely, antisense oligonucleotides, short interfering RNA, messenger RNA (mRNA), guide RNAs, antibodies, expression vector systems, viral particles, peptides, proteins, hormones, nanoparticles, antibiotics, small molecules, and other related molecules and adjuvants

Commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields

research and development in the pharmaceutical and biotechnology fields